North America Genotyping Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2031 – Regional Analysis – by Product Type (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology (Microarray, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption / MALDI-TOF, and Other Technologies), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Other Applications), and End user (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other End Users)

No. of Pages: 147    |    Report Code: BMIRE00025971    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Genotyping Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Genotyping Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Genotyping Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Use in Diagnosis of Genetic and Rare Diseases
5.2 Market Opportunities
  • 5.2.1 Expanding Range of Applications
5.3 Future Trends
  • 5.3.1 Increasing Popularity of Personalized Medicine
5.4 Impact of Drivers and Restraints

6. North America Genotyping Market Regional Analysis

6.1 North America Genotyping Market Overview
6.2 North America Genotyping Market Revenue 2021-2031 (US$ Million)
6.3 North America Genotyping Market Forecast Analysis

7. North America Genotyping Market Analysis – by Product Type

7.1 Instruments
  • 7.1.1 Overview
  • 7.1.2 Instruments: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reagents and Kits
  • 7.2.1 Overview
  • 7.2.2 Reagents and Kits: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Bioinformatics
  • 7.3.1 Overview
  • 7.3.2 Bioinformatics: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Genotyping Services
  • 7.4.1 Overview
  • 7.4.2 Genotyping Services: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Genotyping Market Analysis – by Technology

8.1 Microarray
  • 8.1.1 Overview
  • 8.1.2 Microarray: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Capillary Electrophoresis
  • 8.2.1 Overview
  • 8.2.2 Capillary Electrophoresis: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Sequencing
  • 8.3.1 Overview
  • 8.3.2 Sequencing: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Polymerase Chain Reaction
  • 8.4.1 Overview
  • 8.4.2 Polymerase Chain Reaction: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Matrix-Assisted Laser Desorption / MALDI-TOF
  • 8.5.1 Overview
  • 8.5.2 Matrix-Assisted Laser Desorption / MALDI-TOF: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Other Technologies
  • 8.6.1 Overview
  • 8.6.2 Other Technologies: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

9. North America Genotyping Market Analysis – by Application

9.1 Pharmacogenomics
  • 9.1.1 Overview
  • 9.1.2 Other Technologies: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Diagnostics and Personalized Medicine
  • 9.2.1 Overview
  • 9.2.2 Other Technologies: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Animal Genetics
  • 9.3.1 Overview
  • 9.3.2 Other Technologies: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Agricultural Biotechnology
  • 9.4.1 Overview
  • 9.4.2 Other Technologies: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Other Applications
  • 9.5.1 Overview
  • 9.5.2 Other Technologies: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

10. North America Genotyping Market – North America Analysis

10.1 North America
  • 10.1.1 North America Genotyping Market Breakdown, by Key Country, 2024 and 2031 (%)
  • 10.1.1.1 North America Genotyping Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.1.1 US: North America Genotyping Market Breakdown, by Product Type
    • 10.1.1.1.2 US: North America Genotyping Market Breakdown, by Technology
    • 10.1.1.1.3 US: North America Genotyping Market Breakdown, by Application
  • 10.1.1.2 Canada: North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.2.1 Canada: North America Genotyping Market Breakdown, by Product Type
    • 10.1.1.2.2 Canada: North America Genotyping Market Breakdown, by Technology
    • 10.1.1.2.3 Canada: North America Genotyping Market Breakdown, by Application
  • 10.1.1.3 Mexico : North America Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Genotyping Market Breakdown, by Product Type
    • 10.1.1.3.2 Mexico : North America Genotyping Market Breakdown, by Technology
    • 10.1.1.3.3 Mexico : North America Genotyping Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Genotyping Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Hoffmann-La Roche Ltd.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 QIAGEN NV.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Merck KGaA.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Thermo Fisher Scientific Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 BioTek Instruments, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 TRIMGEN CORPORATION.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Illumina Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Danaher Corp.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Bio-Rad Laboratories Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 GE HealthCare Technologies Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Standard BioTools Inc.
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 Laboratory Corp of America Holdings.
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments
13.13 Beckman Coulter Inc.
  • 13.13.1 Key Facts
  • 13.13.2 Business Description
  • 13.13.3 Products and Services
  • 13.13.4 Financial Overview
  • 13.13.5 SWOT Analysis
  • 13.13.6 Key Developments
13.14 BGI.
  • 13.14.1 Key Facts
  • 13.14.2 Business Description
  • 13.14.3 Products and Services
  • 13.14.4 Financial Overview
  • 13.14.5 SWOT Analysis
  • 13.14.6 Key Developments
13.15 Takara Bio Inc.
  • 13.15.1 Key Facts
  • 13.15.2 Business Description
  • 13.15.3 Products and Services
  • 13.15.4 Financial Overview
  • 13.15.5 SWOT Analysis
  • 13.15.6 Key Developments
13.16 DiaSorin SpA.
  • 13.16.1 Key Facts
  • 13.16.2 Business Description
  • 13.16.3 Products and Services
  • 13.16.4 Financial Overview
  • 13.16.5 SWOT Analysis
  • 13.16.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  • Hoffmann-La Roche Ltd.
  • QIAGEN NV.
  • Merck KGaA.
  • Thermo Fisher Scientific Inc.
  • BioTek Instruments, Inc.
  • TRIMGEN CORPORATION.
  • Illumina Inc.
  • Danaher Corp.
  • Bio-Rad Laboratories Inc.
  • GE HealthCare Technologies Inc.
  • Standard BioTools Inc.
  • Laboratory Corp of America Holdings.
  • Beckman Coulter Inc.
  • BGI.
  • Takara Bio Inc.
  • DiaSorin SpA.
north-america-genotyping-market